In addition, miRNAs down-regulated in the stable CAD compared to the acute CAD patients are possibly involved in regulation of activation of gene expression by sterol regulatory element-binding protein (SREBP) and type II diabetes mellitus pathways (Fig. 5B). The gene discussed is CNBP; the disease is type 2 diabetes mellitus.